Turns out the new incoming-head of Eli Lilly may have the ethics of a slug:

“[W]e are losing scripts to Risperdal for treatment of disruptive kids, because Johnson & Johnson has the data and we don’t.”
-Dr. John Lechleiter

The only problem with this…turns out Lilly’s product is kinda bad:

Because of Zyprexa’s physical side effects, many psychiatrists now say it is appropriate only for severely mentally ill patients. Clinical trials have shown that its tendency to cause dangerous weight gain appears to be especially severe in younger patients. The Food and Drug Administration has for more than a year declined to act upon an application by Lilly to broaden the drug’s label to allow its use in people under 18.
-Lilly E-Mail Discussed Off-Label Drug Use

Let’s review…drug is only to be used in the most dangerous of cases, but the head of Eli Lilly wants them to jack up the number of scrips. Feh.

Rate this topic:

(No Ratings Yet)

 Loading ...